| Literature DB >> 35229250 |
Hao Chen1,2, Ruicong Xue1,2,3, Peisen Huang1,2,3, Yuzhong Wu1,2,3, Wendong Fan1,2,3, Xin He1,2,3, Yugang Dong1,2,3, Chen Liu4,5,6.
Abstract
Stem cell-based therapy for ischemic heart disease (IHD) has become a promising but controversial strategy during the past two decades. The fate and effects of stem cells engrafted into ischemia myocardium are still not fully understood. Stem cell-derived exosomes, a subcategory of extracellular vesicles with nano size, have been considered as an efficient and safe transporter for microRNAs (miRNAs) and a central mediator of the cardioprotective potentials of the parental cells. Hypoxia, pharmacological intervention, and gene manipulation could alter the exosomal miRNAs cargos from stem cells and promote therapeutic potential. Furthermore, several bioengineering methods were also successfully applied to modify miRNAs content and components of exosomal membrane proteins recently. In this review, we outline relevant results about exosomal miRNAs from stem cells and focus on the current strategies to promote their therapeutic efficiency in IHD.Entities:
Keywords: Exosome modifications; Exosomes; Stem cells; miRNAs
Mesh：
Substances：
Year: 2022 PMID： 35229250 DOI： 10.1007/s12265-022-10216-1
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN： 1937-5387 Impact factor: 3.216